Hannover Rück SE (0M9A.L)
| Previous close | N/A |
| YTD return | N/A |
| Expense ratio (net) | N/A |
| Category | N/A |
| Last cap gain | N/A |
| Morningstar rating | N/A |
| Morningstar risk rating | N/A |
| Sustainability rating | N/A |
| Net assets | N/A |
| Beta (5Y monthly) | N/A |
| Yield | N/A |
| 5y average return | N/A |
| Holdings turnover | N/A |
| Last dividend | N/A |
| Average for category | N/A |
| Inception date | N/A |
- EQS Group
Annual General Meeting adopts all proposed resolutions
DGAP-News: Hannover Rück SE / Key word(s): AGM/EGM Annual General Meeting adopts all proposed resolutions 04.05.2022 / 16:30 The issuer is solely responsible for the content of this announcement. Corporate news Annual General Meeting adopts all proposed resolutions Dividend of EUR 5.75 per share approved Corporate culture, partnership-based solutions, capital strength and focus on reinsurance as the basis for sustained profitable growth Hannover, 4 May 2022: The virtual Annual General Meeting of
- EQS Group
Hannover Re generates quarterly profit of EUR 264 million despite substantial losses and confirms earnings guidance
DGAP-News: Hannover Rück SE / Key word(s): Quarter ResultsHannover Re generates quarterly profit of EUR 264 million despite substantial losses and confirms earnings guidance 04.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Corporate newsHannover Re generates quarterly profit of EUR 264 million despite substantial losses and confirms earnings guidance Gross premium up by 13.9% adjusted for exchange-rate effects Major losses in property and casualty reinsura
- EQS Group
Hannover Re reports significantly higher earnings and pays dividend on record level
DGAP-News: Hannover Rück SE / Key word(s): Annual Results10.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Corporate newsHannover Re reports significantly higher earnings and pays dividend on record level Gross premium grows by 12.1% Group net income improves by 39% to EUR 1.23 billion and reaches upper end of guidance Major loss expenditure above expectations Life and health reinsurance incurs pandemic losses of EUR 582 million Return on equity beats targe
